John D. York
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
John D. York has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Shean-Tai Chiou
Department of Pharmacology and Cancer Biology, Howard Hughes Medical Institute, and
4 shared publicationsJoshua P. Frederick
Department of Pharmacology and Cancer Biology, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA
3 shared publicationsLouis C. Megosh
Department of Pharmacology and Cancer Biology, Howard Hughes Medical Institute, and
2 shared publicationsA. Tsahai Tafari
Department of Pharmacology and Cancer Biology, Howard Hughes Medical Institute, and
1 shared publicationAndrew M. Seeds
Department of Pharmacology and Cancer Biology, Howard Hughes Medical Institute, Duke University Medical Center, DUMC 3813, Durham NC 27710, U.S.A.
1 shared publication- Andrew Michael Seeds
Institute of Neurobiology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
1 shared publication
Latest Publications
- 19 June 2012
- Published by Springer Nature
- p. 337
Erratum
- 1 January 2010
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 50 (1) , 324-337
Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes
- 1 January 2010
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 50 (1) , 324-337
Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes
- Open Access
- 1 April 2009
- Published by Elsevier in Journal of Lipid Research
- Vol. 50, S249-S254
Phosphoinositide phosphatases and disease
- 1 April 2009
- Published by Elsevier in Journal of Lipid Research
- Vol. 50, S249-S254
Open AccessPhosphoinositide phosphatases and disease
- Open Access
- 19 August 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (33) , 11605-11612
A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation
Sulfation is an important biological process that modulates the function of numerous molecules. It is directly mediated by cytosolic and Golgi sulfotransferases, which use 3′-phosphoadenosine 5′-phosphosulfate to produce sulfated acceptors and 3′-phosphoadenosine 5′-phosphate (PAP). Here, we identify a Golgi-resident PAP 3′-phosphatase (gPAPP) and demonstrate that its activity is potently inhibited by lithium in vitro . The inactivation of gPAPP in mice led to neonatal lethality, lung abnormalities resembling atelectasis, and dwarfism characterized by aberrant cartilage morphology. The phenotypic similarities of gPAPP mutant mice to chondrodysplastic models harboring mutations within components of the sulfation pathway lead to the discovery of undersulfated chondroitin in the absence of functional enzyme. Additionally, we observed loss of gPAPP leads to perturbations in the levels of heparan sulfate species in lung tissue and whole embryos. Our data are consistent with a model that clearance of the nucleotide product of sulfotransferases within the Golgi plays an important role in glycosaminoglycan sulfation, provide a unique genetic basis for chondrodysplasia, and define a function for gPAPP in the formation of skeletal elements derived through endochondral ossification.
- 19 August 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (33) , 11605-11612
Open AccessA role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation
Sulfation is an important biological process that modulates the function of numerous molecules. It is directly mediated by cytosolic and Golgi sulfotransferases, which use 3′-phosphoadenosine 5′-phosphosulfate to produce sulfated acceptors and 3′-phosphoadenosine 5′-phosphate (PAP). Here, we identify a Golgi-resident PAP 3′-phosphatase (gPAPP) and demonstrate that its activity is potently inhibited by lithium in vitro . The inactivation of gPAPP in mice led to neonatal lethality, lung abnormalities resembling atelectasis, and dwarfism characterized by aberrant cartilage morphology. The phenotypic similarities of gPAPP mutant mice to chondrodysplastic models harboring mutations within components of the sulfation pathway lead to the discovery of undersulfated chondroitin in the absence of functional enzyme. Additionally, we observed loss of gPAPP leads to perturbations in the levels of heparan sulfate species in lung tissue and whole embryos. Our data are consistent with a model that clearance of the nucleotide product of sulfotransferases within the Golgi plays an important role in glycosaminoglycan sulfation, provide a unique genetic basis for chondrodysplasia, and define a function for gPAPP in the formation of skeletal elements derived through endochondral ossification.
- 31 December 2007
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 47 (1) , 10-25
Roles for inositol polyphosphate kinases in the regulation of nuclear processes and developmental biology
- 31 December 2007
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 47 (1) , 10-25
Roles for inositol polyphosphate kinases in the regulation of nuclear processes and developmental biology
- 2 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (40) , 15653-15658
Alterations in an inositol phosphate code through synergistic activation of a G protein and inositol phosphate kinases
In mammals, many cellular stimuli evoke a response through G protein activation of phospholipase C, which results in the lipid-derived production of inositol 1,4,5-trisphosphate (IP 3 ). Although it is well established that IP 3 is converted to numerous inositol phosphates (IPs) and pyrophosphates (PP-IPs) through the action of up to six classes of inositol phosphate kinases (IPKs), it is not clear that these metabolites are influenced by G protein signaling. Here we report that activation of Gα q leads to robust stimulation of IP 3 to IP 8 metabolism. To expose flux through these pathways, genetic perturbation was used to alter IP homeostasis. Coupled expression of a constitutively active Gα q QL and one or more IPK gene products synergistically generated dramatic changes in the patterns of intracellular IP messengers. Many distinct IP profiles were observed through the expression of different combinations of IPKs, including changes in previously unappreciated pools of IP 5 and IP 6 , two molecules widely viewed as stable metabolites. Our data link the activation of a trimeric G protein to a plethora of metabolites downstream of IP 3 and provide a framework for suggesting that cells possess the machinery to produce an IPK-dependent IP code. We imply, but do not prove, that agonist-induced alterations in such a code would theoretically be capable of enhancing signaling complexity and specificity. The essential roles for IPKs in organism development and cellular adaptation are consistent with our hypothesis that such an IP code may be relevant to signaling pathways.
- 2 October 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (40) , 15653-15658
Alterations in an inositol phosphate code through synergistic activation of a G protein and inositol phosphate kinases
In mammals, many cellular stimuli evoke a response through G protein activation of phospholipase C, which results in the lipid-derived production of inositol 1,4,5-trisphosphate (IP 3 ). Although it is well established that IP 3 is converted to numerous inositol phosphates (IPs) and pyrophosphates (PP-IPs) through the action of up to six classes of inositol phosphate kinases (IPKs), it is not clear that these metabolites are influenced by G protein signaling. Here we report that activation of Gα q leads to robust stimulation of IP 3 to IP 8 metabolism. To expose flux through these pathways, genetic perturbation was used to alter IP homeostasis. Coupled expression of a constitutively active Gα q QL and one or more IPK gene products synergistically generated dramatic changes in the patterns of intracellular IP messengers. Many distinct IP profiles were observed through the expression of different combinations of IPKs, including changes in previously unappreciated pools of IP 5 and IP 6 , two molecules widely viewed as stable metabolites. Our data link the activation of a trimeric G protein to a plethora of metabolites downstream of IP 3 and provide a framework for suggesting that cells possess the machinery to produce an IPK-dependent IP code. We imply, but do not prove, that agonist-induced alterations in such a code would theoretically be capable of enhancing signaling complexity and specificity. The essential roles for IPKs in organism development and cellular adaptation are consistent with our hypothesis that such an IP code may be relevant to signaling pathways.
- 12 January 2007
- Published by Portland Press Ltd. in Biochemical Society Symposia
- Vol. 74, 183-197
Inositol polyphosphate kinases: regulators of nuclear function
Recent work has uncovered roles for inositide signalling pathways downstream of phospholipase C activation and inositol 1,4,5-trisphosphate in the regulation of nuclear processes including gene expression, mRNA export and DNA metabolism. The identification of several IPKs (inositol polyphosphate kinases) has renewed interest in the cellular roles of inositol tetra-, penta-, hexa- and pyro-phosphates. Discoveries of inositide receptors and novel mechanisms of inositide action have provided important insights into how such messengers couple to nuclear machinery. In this chapter, we discuss the IPK family members and the nuclear processes that their inositide products regulate.
- 12 January 2007
- Published by Portland Press Ltd. in Biochemical Society Symposia
- Vol. 74, 183-197
Inositol polyphosphate kinases: regulators of nuclear function
Recent work has uncovered roles for inositide signalling pathways downstream of phospholipase C activation and inositol 1,4,5-trisphosphate in the regulation of nuclear processes including gene expression, mRNA export and DNA metabolism. The identification of several IPKs (inositol polyphosphate kinases) has renewed interest in the cellular roles of inositol tetra-, penta-, hexa- and pyro-phosphates. Discoveries of inositide receptors and novel mechanisms of inositide action have provided important insights into how such messengers couple to nuclear machinery. In this chapter, we discuss the IPK family members and the nuclear processes that their inositide products regulate.
- 1 May 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1761 (5-6) , 552-559
Regulation of nuclear processes by inositol polyphosphates
- 1 May 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1761 (5-6) , 552-559
Regulation of nuclear processes by inositol polyphosphates
- 17 August 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (35) , 12612-12617
Generation of phytate-free seeds in Arabidopsis through disruption of inositol polyphosphate kinases
Phytate (inositol hexakisphosphate, IP 6 ) is a regulator of intracellular signaling, a highly abundant animal antinutrient, and a phosphate store in plant seeds. Here, we report a requirement for inositol polyphosphate kinases, AtIPK1 and AtIPK2 β, for the later steps of phytate synthesis in Arabidopsis thaliana . Coincident disruption of these kinases nearly ablates seed phytate without accumulation of phytate precursors, increases seed-free phosphate by 10-fold, and has normal seed yield. Additionally, we find a requirement for inositol tetrakisphosphate (IP 4 )/inositol pentakisphosphate (IP 5 ) 2-kinase activity in phosphate sensing and root hair elongation. Our results define a commercially viable strategy for the genetic engineering of phytate-free grain and provide insights into the role of inositol polyphosphate kinases in phosphate signaling biology.
- 17 August 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (35) , 12612-12617
Generation of phytate-free seeds in Arabidopsis through disruption of inositol polyphosphate kinases
Phytate (inositol hexakisphosphate, IP 6 ) is a regulator of intracellular signaling, a highly abundant animal antinutrient, and a phosphate store in plant seeds. Here, we report a requirement for inositol polyphosphate kinases, AtIPK1 and AtIPK2 β, for the later steps of phytate synthesis in Arabidopsis thaliana . Coincident disruption of these kinases nearly ablates seed phytate without accumulation of phytate precursors, increases seed-free phosphate by 10-fold, and has normal seed yield. Additionally, we find a requirement for inositol tetrakisphosphate (IP 4 )/inositol pentakisphosphate (IP 5 ) 2-kinase activity in phosphate sensing and root hair elongation. Our results define a commercially viable strategy for the genetic engineering of phytate-free grain and provide insights into the role of inositol polyphosphate kinases in phosphate signaling biology.
- 6 June 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (24) , 8454-8459
An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production
Phospholipase C and several inositol polyphosphate kinase (IPK) activities generate a branched ensemble of inositol polyphosphate second messengers that regulate cellular signaling pathways in the nucleus and cytoplasm. Here, we report that mice deficient for Ipk2 (also known as inositol polyphosphate multikinase), an inositol trisphosphate and tetrakisphosphate 6/5/3-kinase active at several places in the inositol metabolic pathways, die around embryonic day 9.5 with multiple morphological defects, including abnormal folding of the neural tube. Metabolic analysis of Ipk2 -deficient cells demonstrates that synthesis of the majority of inositol pentakisphosphate, hexakisphosphate and pyrophosphate species are disrupted, although the presence of 10% residual inositol hexakisphosphate indicates the existence of a minor alternative pathway. Agonist induced inositol tris- and bis-phosphate production and calcium release responses are present in homozygous mutant cells, indicating that the observed mouse phenotypes are a result of failure to produce higher inositol polyphosphates. Our data demonstrate that Ipk2 plays a major role in the synthesis of inositol polyphosphate messengers derived from inositol 1,4,5-trisphosphate and uncovers a role for their production in embryogenesis and normal development.
- 6 June 2005
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (24) , 8454-8459
An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production
Phospholipase C and several inositol polyphosphate kinase (IPK) activities generate a branched ensemble of inositol polyphosphate second messengers that regulate cellular signaling pathways in the nucleus and cytoplasm. Here, we report that mice deficient for Ipk2 (also known as inositol polyphosphate multikinase), an inositol trisphosphate and tetrakisphosphate 6/5/3-kinase active at several places in the inositol metabolic pathways, die around embryonic day 9.5 with multiple morphological defects, including abnormal folding of the neural tube. Metabolic analysis of Ipk2 -deficient cells demonstrates that synthesis of the majority of inositol pentakisphosphate, hexakisphosphate and pyrophosphate species are disrupted, although the presence of 10% residual inositol hexakisphosphate indicates the existence of a minor alternative pathway. Agonist induced inositol tris- and bis-phosphate production and calcium release responses are present in homozygous mutant cells, indicating that the observed mouse phenotypes are a result of failure to produce higher inositol polyphosphates. Our data demonstrate that Ipk2 plays a major role in the synthesis of inositol polyphosphate messengers derived from inositol 1,4,5-trisphosphate and uncovers a role for their production in embryogenesis and normal development.